You are here

  • Home
  • Archive
  • Volume 55, Issue 6
  • Correction: Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study

Article Text

Article menu

See original article:

Download PDFPDF

Correction
Correction: Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study

https://doi.org/10.1136/jmedgenet-2016-104178corr1

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Hughes DA, Nicholls K, Shankar SP, et al. Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study. J Med Genet 2017;54:288–96.

    The correct trial protocol number for this study is: NCT01218659.

    Linked Articles

    • Therapeutics
      Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study
      Derralynn A Hughes Kathleen Nicholls Suma P Shankar Gere Sunder-Plassmann David Koeller Khan Nedd Gerard Vockley Takashi Hamazaki Robin Lachmann Toya Ohashi Iacopo Olivotto Norio Sakai Patrick Deegan David Dimmock François Eyskens Dominique P Germain Ozlem Goker-Alpan Eric Hachulla Ana Jovanovic Charles M Lourenco Ichiei Narita Mark Thomas William R Wilcox Daniel G Bichet Raphael Schiffmann Elizabeth Ludington Christopher Viereck John Kirk Julie Yu Franklin Johnson Pol Boudes Elfrida R Benjamin David J Lockhart Carrolee Barlow Nina Skuban Jeffrey P Castelli Jay Barth Ulla Feldt-Rasmussen
      Journal of Medical Genetics 2016; 54 288-296 Published Online First: 10 Nov 2016. doi: 10.1136/jmedgenet-2016-104178